European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.18% to 1,390.31 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and 3D printer company Materialise (MTLS), which surged 20% and 15%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and petroleum refiner Equinor (EQNR), which rose 3.4% and 2.8%, respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS), which fell 2.1% and then biopharmaceutical company Grifols (GRFS) retreated 1.2%. They were followed by pharmaceutical company Novo Nordisk (NVO) and telecommunications company VEON (VEON), which were down 1% and 0.6%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB), which added 19%, and then biopharmaceutical firm Akari Therapeutics (AKTX), which gained 11%. Financial services company Barclays (BCS) and Lloyds Banking Group (LYG) increased 5.5% and 1.4%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and Adaptimmune Therapeutics (ADAP), which lost 12% and 1.9%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which were down 1.7% and 1.3%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。